APA (7th ed.) Citation

Jamrozik, M., Piska, K., Bucki, A., Koczurkiewicz-Adamczyk, P., Sapa, M., Władyka, B., . . . Kołaczkowski, M. (2023). In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics. Molecules, 28(9), 3767. https://doi.org/10.3390/molecules28093767

Chicago Style (17th ed.) Citation

Jamrozik, Marek, Kamil Piska, Adam Bucki, Paulina Koczurkiewicz-Adamczyk, Michał Sapa, Benedykt Władyka, Elżbieta Pękala, and Marcin Kołaczkowski. "In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics." Molecules 28, no. 9 (2023): 3767. https://doi.org/10.3390/molecules28093767.

MLA (9th ed.) Citation

Jamrozik, Marek, et al. "In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics." Molecules, vol. 28, no. 9, 2023, p. 3767, https://doi.org/10.3390/molecules28093767.